Abstract:Aim: To observe the sexual disturbance in male patients with schizophrenia caused by chlorpromazine, risperidone, quetiapine and olanzapine and their associations with the changes of blood glucose and blood lipids. Methods: Totally 100 male inpatients with schizophrenia in the Brain Hospital affiliated to Nanjing Medical University between October 2003 and October 2004 were randomly divided into chlorpromazine group (n=25), risperidone group (n= 25), quetiapine group(n=25) and olanzapine group (n=25).There were insignificant differences in age, educational background, disease course, economic status, couples'relationship and the baseline scores of positive and negative syndrome scale (PANSS). The patients in the four groups were treated with chlorpromazine (25 mg/tablet), risperidone (1 mg/tablet), quetiapine (200 mg/tablet) and olanzapine (5 mg/tablet) respectively. The levels of blood glucose, triaglyceride, high density lipoprotein cholesterol (HDL-C),low density lipoprotein cholestero (LDL-C),apolipoprotein A and apolipoprotein B were detected with enzyme chromatometry,direct method and immunoturbidimetry before treatment and 4 and 8 weeks after treatment. The baseline data of sexual function of the patients were provided by their spouses before treatment, and they were further evaluated after their psychiatric symptoms were relieved. The mental status of the patients with schizophrenia were generally relieved after 4 weeks, and rehabilitated after 8 weeks, and they could finished the questionnaire inventory independently. The sexual function of the patients were assessed with the self-designed male sexual function scale before treatment and 8,12 and 16 weeks after treatment, the scale included 4 factor scores of sexuality, sexual arousal, sexual orgasm and sexual satisfactory degree, and the general factor score of sexual function was the sum up of the 4 factor scores. Results: There were 17, 19, 19 and 18 cases in the chlorpromazine group, risperidone group, quetiapine group and olanzapine group involved in the analysis of results respectively. (1) The incidence rate of hyposexuality: It was significantly lower in the quetiapine group than in the chlorpromazine group and risperidone group at 8 weeks (21.1%, 58.8%, 63.2%, F=5.386, 6.909, P< 0.05). (2) Incidence rate of difficulty in sexual arousal: It was significantly lower in the quetiapine group than in the chlorpromazine group at 8, 12 and 16 weeks (21.1%, 21.1%, (1) 5.8%; 64.7%, 70.6%, 70.6%, F=7.034, 6.916,11.9, P< 0.05), and also remarkably lower than those in the risperidone group (63.2%, 47.4%, 57.9%, F=6.909, 2.923, 7.238, P < 0.05). (3) Level of blood glucose: After 8 weeks, it was significantly than the baseline level in the chlorpromazine group (F=7.224,P < 0.01) and olanzapine group (F=3.187,P= 0.05), but not significantly different from the baseline level in the risperidone group and quetiapine group (P>0.05). (4) Level of triglyceride: At 8 weeks, it was significantly higher than the baseline level in the olanzapine group (F=8.344, P < 0.05),but not significantly different from the baseline level in the chlorpromazine group, risperidone group and quetiapine group (P>0.05). Conclusion: Chlorpromazine and risperidone have different influence on the sexuality and sexual arousal.Chlorpromazine can lead to the obvious increase of the levels of blood glucose, LDL-C and apolipoprotein B. Quetiapine has little influence on levels of blood glucose, blood lipids and sexual arousal. Olanzapine has certain influence on blood glucose, triglyceride, apolipoprotein B, sexuality and sexual arousal.

Sex Difference in Effects of Typical and Atypical Antipsychotics on Glucose-Insulin Homeostasis and Lipid Metabolism in First-Episode Schizophrenia.

The side-effects of four psychotropic drugs on the glucose metabolism and lipid metabolism

Effects of paliperidone extended-release tablets (paliperidoneer) and olanzapine on metabolic profile, weight, insulin resistance and beta-cell function in schizophrenic patients: a randomized 12-week study

[Effects of Ziprasidone and Olanzapine on Glucose and Lipid Metabolism in First-Episode Schizophrenia].

Characteristics of the sexual disturbance caused by chlorpromazine, risperidone, quetiapine and olanzapine and their associations with the changes of blood glucose and blood lipids in male patients with schizophrenia

Influence of Atypical Antipsychotics on the Glucose and Lipid Metabolism of Female First-Episode Schizophrenia

A Randomized, 13-Week Study Assessing the Efficacy and Metabolic Effects of Paliperidone Palmitate Injection and Olanzapine in First-Episode Schizophrenia Patients

Effect of Long-Term Monotherapy of Atypical Antipsychotics on the Levels of Body Mass Index,Leptin Concentration and Insulin Resistance in Patients with Schizophrenia

The difference of side-effects of four psychotropic drugs on the lipid metabolism in schizophrenic patients with their first episode

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia

Comparison of Short-term Metabolic Risk in First-episode Young-adult Schizophrenia Treated with Aripiprazole and Olanzapine

The effects of risperidone and olanzapine on the glucose metabolism and lipid metabolism in elderly patients with schizophrenia

Sex differences in plasma lipid profiles, but not in glucose metabolism in patients with first-episode antipsychotics-naïve schizophrenia

A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients

Metabolic Effects Of 7 Antipsychotics On Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

Evaluation of Clinical Correlation between Insulin Resistance and Antipsychotic Drug Therapy in Patients with Schizophrenia

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia

Male Sex May Be Associated with Higher Metabolic Risk in First-Episode Schizophrenia Patients: A Preliminary Study

Influence of risperidone, clozapine and metabolites of clozapine on insulin secretion function of rat islets cultured in vitro

Effects of antipsychotic on pituitary-gonadal axis in male patients with schizophrenia

Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats